2026 Neuroendocrine Cancer Patient Conference in Atlanta

Heather Cole, M.D.

Assistant Professor

Radiology & Radiological Sciences

Associate Program Director

Nuclear Medicine Residency & Fellowship Programs.

Heather Cole, MD, joined VUMC Radiology faculty as an Assistant Professor in 2024. She specializes in Nuclear Medicine and Image Guided Procedures.  

Currently, Dr. Cole serves as Director for the Neuroendocrine Tumor Board at Vanderbilt, the Associate Program Director for the Nuclear Medicine Residency and Fellowship Programs and the Nuclear Medicine Education Director for the Diagnostic Radiology Residency Program. She is the Director of the FCC Radiology elective course through Vanderbilt University School of Medicine. 

Dr. Cole received her undergraduate degree from Colorado State University and went to medical school at the University of Tennessee Health Science Center. She completed her residency here at Vanderbilt University Medical Center. During her residency, Dr. Cole was conference chief (2023-2024), received the "Radiology Resident of the Year" award (2023-2024), as well as the "Radiology Resident Teacher of the Year" award (2022). As a trainee, she helped start an ultrasound clinic within Shade Tree Clinic.

Seth J. Concors, MD

Gastrointestinal Surgical Oncology

Emory University

Seth Concors, MD is an academic surgical oncologist at Emory University and the Winship Cancer Institute, where he serves as Associate Program Director for both the General Surgery Residency and the Complex General Surgical Oncology Fellowship, and Director of the Surgical Oncology Research Fellowship. He leads Emory’s Peritoneal Surface Malignancy and Neuroendocrine Tumor surgical programs, with clinical and research interests focused on gastrointestinal neuroendocrine tumors, cytoreductive surgery/HIPEC, and survivorship outcomes. Dr. Concors is actively involved in national surgical societies including SSO, SSAT, NANETS, ACS, and ECOG-ACRIN, and his work emphasizes multidisciplinary collaboration, prospective outcomes research, and surgical education. He is committed to advancing patient-centered cancer care while mentoring the next generation of surgical oncologists.

Po Hien Ear, PhD

Scientist

Associate Professor

Department of Hematology and Medical Oncology

Emory University

Dr. Ear is an Associate Professor in the Department of Hematology and Medical

Oncology. She is the Leader of the NET Research Team at the Emory Winship Cancer Institute. Dr. Ear is internationally renowned for her groundbreaking work on establishing

NET 3D cultures and patient-derived xenograft models, elucidating NET tumor biology, and pioneering novel therapeutic approaches for neuroendocrine cancers. 

Dr. Ear has received numerous external grants to support her research. Currently, she serves as the Basic Science Principal Investigator for Project 3 of the NET SPORE (Specialized Program of Research Excellence), which focuses on determining the impact of GLP-1

drugs on small bowel and pancreatic NETs. In addition, she receives funding from the NET Research Foundation and the Department of Defense to investigate the mechanisms underlying NET resistance to anticancer therapies and to develop novel agents that specifically target and eliminate NET cancer cells.

Udhayvir Singh Grewal, MD

Medical Oncologist

Emory University School of Medicine

Udhayvir S. Grewal, MD, is a gastrointestinal and neuroendocrine tumor (GI/NET) medical oncologist at the Winship Cancer Institute of Emory University and an Assistant Professor of Medical Oncology at the Emory University School of Medicine in Atlanta, Georgia. His research focuses on drug development and care-delivery innovations for patients with neuroendocrine tumors. Dr. Grewal serves on the North American Neuroendocrine Tumor Society (NANETS) Membership & Diversity Committee and the European Neuroendocrine Tumor Society (ENETS) Grade 3 NENs Task Force. 

After medical school at Government Medical College in Patiala, India, Dr. Grewal completed his internal medicine residency at LSU Health Sciences Center–Shreveport and a hematology/medical oncology fellowship at the University of Iowa Holden Comprehensive Cancer Center, where he also remains an active collaborator with the UIowa NET SPORE team.

Garima Gupta, MD

Medical Oncologist

University of Alabama Birmingham

O'Neal Cancer Center

Dr. Garima Gupta is an Assistant Professor of Medicine at the O'Neal Cancer Center, University of Alabama Birmingham. Her clinical practice focuses on patients with GI malignancies and Neuroendocrine Tumors.

Dr. Gupta graduated from St. George's University with her medical degree in 2010. She then moved to the National Institutes of Health in Bethesda, Maryland and trained with Dr. Karel Pacak on Pheochromocytoma and Paraganglioma. She served as a third year chief resident during her Internal Medicine training and was awarded the Deepak Bhandari award for research and academic excellence. Following this, she completed her Hematology/Oncology fellowship at Markey Cancer Center, University of Kentucky and was mentored by Dr. Lowell Anthony on Neuroendocrine Tumors. She received a letter of achievement for academic excellence and research excellence award at University of Kentucky. Dr. Gupta now co-leads the NET multidisciplinary clinic at UAB and serves as the medical director of the inpatient Oncology consult service. 

Daniel M. Halperin, MD

Medical Oncologist

Associate Professor & Vice Chair of Clinical Affairs, Department of Hematology and Medical Oncology

Emory University

A board-certified medical oncologist, Daniel M. Halperin, MD, specializes in complex multidisciplinary care for neuroendocrine cancers. He has expertise in applying immunotherapy and radioligand therapy to treat patients with neuroendocrine tumors (NETs). He is a member of the gastrointestinal oncology team at Winship Cancer Institute at Emory Midtown.

Dr. Halperin is an associate professor and serves as vice chair for clinical affairs in the Department of Hematology and Medical Oncology at Emory University School of Medicine. As vice chair of clinical affairs, he works with the department chair and other leaders to plan, communicate and execute Winship strategies and organizational goals in the clinical arena, and to support and direct the performance of physician faculty members in the department.

Dr. Halperin received his medical degree from Weill Cornell Medical College in New York City, New York. He completed his internal medicine residency at Brigham and Women's Hospital in Boston, Massachusetts and his medical oncology training at University of Texas MD Anderson Cancer Center in Houston, Texas.

Megan A. Lilly, MD

Interventional Radiologist

Emory University

Dr. Meghan Lilly is an interventional radiologist. After earning her medical degree from St. George's University, Dr. Lilly completed a surgical internship and residency with Pinnacle Health Hospital. She then completed diagnostic radiology residency training at SUNY Downstate Medical Center followed by a fellowship in vascular and interventional radiology with New York - Presbyterian Hospital of the Columbia University Irving Medical Center.

Saima Muzahir, MD, FCPS, FRCPE

Nuclear Medicine Physician

Emory University Hospital

Saima Muzahir, MD, FCPS (Fellow college of Physicians and Surgeons Pakistan),

FRCPE (Fellow Royal College of Physicians Edinburgh) is Associate professor of Radiology; serving as Enterprise Theranostics lead in the Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University Hospital, Atlanta Georgia. 

Dr Muzahir is the Associate Program Director for Emory Molecular Imaging and Therapy (MIT) fellowship. She is the program manager for RAD-AID Pakistan and is currently serving as the vice president for Pakistan Society of Nuclear Medicine (PSNM). Dr Muzahir received her medical degree from Nishtar Medical College Pakistan and completed a four-year residency in Nuclear Medicine at Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore Pakistan.

After completing her training in Pakistan, she moved to the United States and did residency in Nuclear Medicine at the University of Iowa Hospitals and Clinics, Iowa City, followed by a PET-CT fellowship from University of Wisconsin Madison. Dr. Muzahir is a Board of Director for SNMMI General Clinical Nuclear Medicine Council and also serves as a Director for American Board of Nuclear Medicine. Dr Muzahir’s research interests include radioligand therapies and oncologic PET-CT imaging.